Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization: A correlation with WHO histologic subtypes

Cancer

Volumn 77, Issue 2, 1996, Pages 231-236

  Tsai, Sen Tien ^a,b   Jin, Ying Tai ^a   Su, Ih Jen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

EBER1; in situ hybridization; metastasis; nasopharyngeal carcinoma (NPC)

Indexed keywords

VIRUS RNA;

ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS EXPRESSION; WORLD HEALTH ORGANIZATION;

BASE SEQUENCE; CARCINOMA; DNA PRIMERS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; RNA, VIRAL; WORLD HEALTH ORGANIZATION;

EID: 0030022339     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.0.CO;2-P     Document Type: Article

References (37)

1. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968;59:94-101.
2. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt lymphoma. Lancet 1964;1:702-3.
3. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 1987;129:86-91.
4. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991;77:799-808.
5. Greenspan D, Greenspan JS, Conant M, Petersen V, Silverman S Jr., De Souza Y. Oral "hairy" leukoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 1984;2(8407):831-4.
6. Gilligan K, Rajadurai P, Resnick L, Raab-traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA 1990;87:8790-4.
7. Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993;143:1250-4.
8. Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC. Detection of Epstein-Barr virus DNA sequence in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol 1990;28:2398-2402.
9. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Im J Cancer 1976;17:1-7.
10. Zur Hausen H, Schulte-holthausen H, Klein G, Henle W, Henle G, Clifford P, et al. EBV DNA in biopsies of Burkitt's tumours and anaplastic carcinomas of the nasopharynx. Nature 1970;228:1056-8.
11. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988;69:1051-65.
12. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992;66:2689-97.
13. Wu TC, Mann RB, Epstein JI, Macmabon E, Lee WA, Charache P, et al. Abundant expression of EBER 1 small nuclear RNA in nasopharyngeal carcinoma. Am J Pathol 1991; 138:1461-9.
14. Shanmugaratnam K, Sobin LH. Histological typing of upper respiratory tract tumours. International Histological Classification of Tumours. No. 19. Geneva: WHO, 1978.
15. Tsai ST, Jin YT, Wu TC. Synthesis of PCR-derived digoxigenin-labelled DNA probes for in situ detection of EBERs in Epstein-Barr virus-infected cells. J Virol Methods 1995; 54:67-74.
16. Lanier AP, Bornkamm GW, Henle W, Henle G, Bender TR, Talbot ML, et al. Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA. Int J Cancer 1981;28:301-5.
17. Raab-traub N, Flynn K, Pearson G, Huang A, Levine P, Lanier A, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987;39:25-9.
18. Akao I, Sato Y, Mukai K, Uhara H, Furuya S, Hoshikawa T, et al. Detection of Epstein-Barr virus DNA in formalin-fixed paraffin embedded tissues of nasopharungeal carcinoma using polymerase chain reaction and in situ hybridization. Laryngoscope 1991;101:179-83.
19. Brousset P, Butet V, Chittal S, Selves J, Delsol G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab Invest 1992;67:457-64.
20. Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF, Cooper PH, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr virus by in situ hybridization. Am J Surg Pathol 1989; 13:625-31.
21. Pearson GR, Weiland LH, Neel HB, Taylor W, Earle J, Mulroney SE, et al. Application of Epstein Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 1983;51:260-8.
22. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974;71: 4737-41.
23. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991;65:17-24.
24. Dickens P, Srivastava G, Loke SL, Chan CW, Liu YT. Epstein-Barr virus in nasopharyngeal carcinomas from Chinese patients in Hong Kong. J Clin Pathol 1992;45:396-7.
25. Hsu MM, Tu SM. Nasopharyngeal carcinoma in Taiwan: clinical manifestations and results of therapy. Cancer 1983;52:362-8.
26. Chen CL, Wen WN, Chen JY, Hsu MM, Hsu HC. Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization. Intervirology 1993;36:91-8.
27. Yeung WM, Zong YS, Chiu CT, Chan KH, Sham JST, Choy TK, et al. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ, Int J Cancer 1993;53:746-50.
28. Hsu HC, Chen CL, Hsu MM, Lin TC, Tu SM, Huang SC. Pathology of nasopharyngeal carcinoma: proposal of a new histological classification correlated with prognosis. Cancer 1987;59:945-51.
29. Feinmesser R, Miyazaki I, Cheung R, Freeman JL, Noyek AM, Dosch HM. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine needle aspiration. N Engl J Med 1992;326:17-21.
30. Walter MA, Menarguez-palanca J, Peiper SC. Epstein-Barr virus detection in neck metastases by polymerase chain reaction. Laryngoscope 1992;102:481-5.
31. Ohshima K, Kikuchi M, Masuda YI, Sumiyoshi Y, Eguchi F, Mohtai H, et al. Epstein-Barr viral genomes in carcinoma metastatic to lymph nodes: Association with nasopharyngeal carcinoma. Acta Pathol Jpn 1991;41:437-43.
32. Ahmad A, Stefani S. Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients. J Surg Oncol 1986;33:194-7.
33. Tang SGJ, Lin FJ, Chen MS, Liaw CC, Leung WM, Hong JH. Prognostic factors of nasopharyngeal carcinoma: a multivariate analysis, Int J Radiat Oncol Biol Phys 1990;19:1143-9.
34. Teo P, Leung SF, Yu P, Lee WY, Shiu W. A retrospective comparison between different stage classification for nasopharyngeal carcinoma. Br J Radiol 1991;64:901-8.
35. De-Vathaire F, Sancho-Garnier H, de-the H, Pieddeloup C, Schwaab G, Ho TH, et al. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma: a multicenter follow-up study. Int J Cancer 1988;42:176-81.
36. Leyvraz S, Werner H, Chahinian AP, Perlmann C, Klein G, Gordon R, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985;312:1296-9.
37. Huang DP, Ng HK, Ho YH, Chan KM. Epstein-Barr virus-associated undifferentiated carcinoma of the parotid gland. Histopathology 1988;13:509-17.